Anticoagulation in Atrial Fibrillation with Prior Intracranial Haemorrhage

This research article presents a systematic review and meta-analysis evaluating the use of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) in patients with atrial fibrillation who have previously suffered an intracranial hemorrhage. Analyzing data from five large observational studies, the authors found that DOACs are associated with a reduced risk of recurrent bleeding, ischaemic stroke, and all-cause mortality compared to traditional blood thinners. However, the study notes that the certainty of evidence remains moderate to very low due to the potential for residual confounding and the lack of randomized controlled trials for this specific high-risk group. The findings suggest that while DOACs appear to be a safer and more effective alternative, treatment decisions should be individualized rather than based on a definitive change in clinical practice. Ultimately, the researchers call for more prospective evidence and stratified analyses to better guide clinicians balancing the complex risks of stroke prevention and recurrent brain bleeds.